doi: 10.1016/s0014-5793(01)02323-7.
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)
Affiliations
- PMID: 11311239
- DOI: 10.1016/s0014-5793(01)02323-7
Item in Clipboard
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)
FEBS Lett.
.
Free article
Abstract
ADAMTS4 (aggrecanase-1) is considered to play a key role in the degradation of aggrecan in arthritides. The inhibitory activity of tissue inhibitors of metalloproteinases (TIMPs) to ADAMTS4 was examined in an assay using aggrecan substrate. Among the four TIMPs, TIMP-3 inhibited the activity most efficiently with an IC(50) value of 7.9 nM, which was at least 44-fold lower than that of TIMP-1 (350 nM) and TIMP-2 (420 nM) and >250-fold less than that of TIMP-4 (2 microM for 35% inhibition). These results suggest that TIMP-3 is a potent inhibitor against the aggrecanase activity of ADAMTS4 in vivo.
Similar articles
-
Aggrecanase and aggrecan degradation in osteoarthritis: a review.J Int Med Res. 2008 Nov-Dec;36(6):1149-60. doi: 10.1177/147323000803600601. J Int Med Res. 2008. PMID: 19094423 Review.
-
[Role of aggrecanase and MMP in cartilage degradation].Clin Calcium. 2004 Jul;14(7):38-44. Clin Calcium. 2004. PMID: 15577074 Review. Japanese.
-
ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.J Biol Chem. 2002 May 3;277(18):16059-66. doi: 10.1074/jbc.M108607200. Epub 2002 Feb 19. J Biol Chem. 2002. PMID: 11854269
-
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.Osteoarthritis Cartilage. 2001 Aug;9(6):539-52. doi: 10.1053/joca.2001.0427. Osteoarthritis Cartilage. 2001. PMID: 11520168
-
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).J Biol Chem. 2001 Apr 20;276(16):12501-4. doi: 10.1074/jbc.C000848200. Epub 2001 Jan 23. J Biol Chem. 2001. PMID: 11278243
Cited by
-
ADAMTS4 is involved in the production of the Alzheimer disease amyloid biomarker APP669-711.Mol Psychiatry. 2023 Apr;28(4):1802-1812. doi: 10.1038/s41380-023-01946-y. Epub 2023 Feb 1. Mol Psychiatry. 2023. PMID: 36721026 Free PMC article.
-
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition.J Med Chem. 2022 Oct 27;65(20):13505-13532. doi: 10.1021/acs.jmedchem.2c01177. Epub 2022 Oct 17. J Med Chem. 2022. PMID: 36250680 Free PMC article. Review.
-
ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.Adv Pharmacol. 2022;94:255-363. doi: 10.1016/bs.apha.2021.11.002. Epub 2022 Jan 24. Adv Pharmacol. 2022. PMID: 35659374 Free PMC article.
-
Disintegrin and Metalloproteinases (ADAMs [A Disintegrin and Metalloproteinase] and ADAMTSs [ADAMs With a Thrombospondin Motif]) in Aortic Aneurysm.Hypertension. 2022 Jul;79(7):1327-1338. doi: 10.1161/HYPERTENSIONAHA.122.17963. Epub 2022 May 11. Hypertension. 2022. PMID: 35543145 Free PMC article. Review.
-
Inhibition of Pathological Increased Matrix Metalloproteinase (MMP) Activity for Improvement of Bone Regeneration in Diabetes.Life (Basel). 2022 Jan 18;12(2):134. doi: 10.3390/life12020134. Life (Basel). 2022. PMID: 35207422 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
